Answers are grounded in this paper and cite their sources.
"ICU Resource Use in Critically III Patients following Chimeric Antigen Receptor T-Cell Therapy." American Journal of Respiratory and Critical Care Medicine, 202(8), pp. 1184–1187
No takes yet. Share an insight, caveat, or question.
Brown et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: